Clinical Remission Demonstrated with Oral Ozanimod in the Overall Population and Across Multiple Subgroups of Patients with Moderately to Severely Active Ulcerative Colitis in the TOUCHSTONE Trial

Brian G. Feagan  1     William Sandborn  2     Geert R. D'Haens  3     Steve Hanauer  4     Douglas C. Wolf  5     Severine Vermeire  6     Subrata Ghosh     Annkatrin Petersen Jappelli     Steven Ye Hua     Kevin Shan     W Jerry Liu    
1 Robarts Clinical Trials Inc.,London,Canada
2 University of California,San Diego,United States
3 AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center,Amsterdam,Netherlands
4 Feinberg School of Medicine,San Diego,United States
5 Atlanta Gastroenterology Associates,Atlanta,United States
6 University Hospital Leuven,Leuven

IBD I (Posters)

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing